To compare the prognostic value of the DECAF score, the modified DECAF score, in predicting in-hospital mortality of patients with AECOPD

Abstract

Background & Methods: The aim of the study is to compare the prognostic value of the DECAF score, the modified DECAF score, in predicting in-hospital mortality of patients with AECOPD. Criteria for COPD Exacerbation any patient with a worsening of more than two respiratory symptoms for two or more consecutive days can be considered as exacerbation. Results: Majority of the non- survivors had a DECAF score of 4 & above. Most of the survivors had a DECAF score of 0 (36.2%) From this we can conclude that the higher the DECAF score, the more the mortality & this is statistically significant (p - value: 0.000) Conclusion: BAP-65 score can be used as a tool for evaluating & predicting the patient mortality based on minimum number of invasive tests & initial status of presentation of the patient. The BAP-65's components are virtually impartial. This feature emphasizes that this score is consistent & reliable all qualities that are essential for any potential clinical tool. We find that compared to DECAF, modified DECAF, the BAP-65 score had a greater specificity, a higher AUROC, & thus, was a better predictor of in-hospital mortality in patients with AECOPD.